JUN 24, 2019 09:43 AM PDT

'Sugar-coating' proteins to treat pancreatitis?

WRITTEN BY: Nouran Amin

A powerful biomarker created by complex sugar molecules, called CA19-9, may be a target for the treatment of pancreatitis. Pancreatitis is an inflammatory disease of the pancreas that results in 275,000 annual hospitalizations in the United States. Individuals with hereditary pancreatitis are at risk in developing pancreatic cancer.

Learn more about pancreatitis:

"Pancreatitis is required for developing pancreatic cancer, and we might be able to prevent that transition in patients with pancreatitis by targeting CA19-9," says Dannielle Engle, a former Cold Spring Harbor Laboratory (CSHL) Cancer Center postdoctoral fellow and appointed Assistant Professor at Salk Institute "By targeting CA19-9 with antibodies in animal models, we were able to reduce the severity of pancreatitis and even prevent it from occurring."

Credit, Cold Spring Harbor Laboratory (CSHL): Pancreatic lineage immunofluorescence (IF) of the whole body, R;F CA19-9 mouse model.

Findings were published in the journal Science and describes that mice who produced CA19-9--a complex sugar structure that coats many proteins but had not been previously ascribed with any particular function--surprisingly developed severe pancreatitis. CA19-9 was also shown to dramatically result in the the growth of pancreatic tumors. Overall, the findings conclude that CA19-9 may be an attractive therapeutic target for pancreatitis.

"This is one of those unique opportunities where prophylactic intervention of pancreatitis may lead to prevention of pancreatic cancer in at-risk patients," Engle said.

An application was filed by CSHL in current pending status for the use of CA19-9 antibodies for treating and preventing pancreatitis.

Source: Cold Spring Harbor Laboratory (CSHL)

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 19, 2020
Microbiology
JAN 19, 2020
Antibody Discovered That May be the Key to a Universal Flu Vaccine
Instead of designing a new flu vaccine every year, researchers have made a breakthrough that may lead to a single vaccine that protects against all strains....
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Gene Variant Could Be a Therapeutic Target For Alzheimer Disease
A variation in genetics for an individual at high-risk for Alzheimer development has defied the odds for being dementia-free way beyond anticipated. The in...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Psychedelic DMT Creates Vivid Waking Dream State in Brain
In a new study, scientists at Imperial College London investigated how powerful psychedelic dimethyltryptamine (DMT) alters the brain’s electrical ac...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Parkinson's Drug Reduces Hallucinations in Dementia Patients
Pimavanserin, also known as Nuplazid, was approved in the US to treat Parkinson’s-related psychosis in 2016. Now, new research has shown that it also...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Magic Mushrooms Pass First Clinical Trial Against Depression
With the efficacy of selective serotonin reuptake inhibitors such as Prozac increasingly coming under question, the search for new pharmaceutical treatment...
JAN 19, 2020
Cardiology
JAN 19, 2020
New Protein Therapy Improves Heart Attack Survival Rates
Heart disease is the top killer in the Western world. This is partially because, if one manages to survive an initial heart attack, oftentimes the scar tis...
Loading Comments...